(S)-2-(3-Amino-4-((S)-2-amino-5-guanidinopentanamido)-benzamido)-3-(1H-indol-3-yl)propanoic Acid

ID: ALA3416730

Chembl Id: CHEMBL3416730

PubChem CID: 118734297

Max Phase: Preclinical

Molecular Formula: C24H30N8O4

Molecular Weight: 494.56

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCCC[C@H](N)C(=O)Nc1ccc(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)cc1N

Standard InChI:  InChI=1S/C24H30N8O4/c25-16(5-3-9-29-24(27)28)22(34)31-19-8-7-13(10-17(19)26)21(33)32-20(23(35)36)11-14-12-30-18-6-2-1-4-15(14)18/h1-2,4,6-8,10,12,16,20,30H,3,5,9,11,25-26H2,(H,31,34)(H,32,33)(H,35,36)(H4,27,28,29)/t16-,20-/m0/s1

Standard InChI Key:  VAPOMUBVLCEHNL-JXFKEZNVSA-N

Alternative Forms

  1. Parent:

    ALA3416730

    ---

Associated Targets(Human)

ERAP1 Tchem Endoplasmic reticulum aminopeptidase 1 (581 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERAP2 Tchem Endoplasmic reticulum aminopeptidase 2 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNPEP Tchem Cystinyl aminopeptidase (313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 494.56Molecular Weight (Monoisotopic): 494.2390AlogP: 0.70#Rotatable Bonds: 11
Polar Surface Area: 225.23Molecular Species: ZWITTERIONHBA: 6HBD: 9
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 12#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.82CX Basic pKa: 11.98CX LogP: -1.66CX LogD: -2.27
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.08Np Likeness Score: -0.20

References

1. Papakyriakou A, Zervoudi E, Tsoukalidou S, Mauvais FX, Sfyroera G, Mastellos DC, van Endert P, Theodorakis EA, Vourloumis D, Stratikos E..  (2015)  3,4-diaminobenzoic acid derivatives as inhibitors of the oxytocinase subfamily of M1 aminopeptidases with immune-regulating properties.,  58  (3): [PMID:25635706] [10.1021/jm501867s]

Source